Showing results (131-140 of 235) with videos related to

Sort By:
Pageof 24
Global Heart|January 26, 2024
World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 UpdateLiliana Laranjo, Fernando Lanas, Marie Chan Sun, et al.
Vaccine|March 21, 2026
Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trialAdora Rooyakkers, Lingyun Ye, Pedro E Cahn, et al.
Global Heart|September 2, 2022
World Heart Federation Roadmap for Digital Health in CardiologyJasper Tromp, Devraj Jindal, Julie Redfern, et al.
Lancet Regional Health. Americas|April 2, 2025
Prediction of cardiovascular risk: validation of a non-laboratory and a laboratory-based score in a Brazilian community-based cohort of the PURE studyGustavo Bernardes de Figueiredo Oliveira, Rafael Amorim Belo Nunes, Lucas Bassolli de Oliveira Alves, et al.
Journal of Hypertension|May 7, 2020
May measurement month 2017: Latin AmericaEduardo C D Barbosa, Agustin Ramirez, Thomas Beaney, et al.
Neurology|March 8, 2023
Depressive Symptoms and Risk of Acute Stroke: INTERSTROKE Case-Control StudyRobert P Murphy, Catriona Reddin, Annika Rosengren, et al.
Lancet (London, England)|December 26, 2021
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trialScott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, et al.
American Heart Journal|September 21, 2015
Heart failure in low- and middle-income countries: background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)Hisham Dokainish, Koon Teo, Jun Zhu, et al.
JAMA|April 18, 2013
Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) studyKoon Teo, Scott Lear, Shofiqul Islam, et al.
European Journal of Heart Failure|September 8, 2022
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trialKelley R H Branch, Gilles R Dagenais, Alvaro Avezum, et al.
Pageof 24